首页> 中文期刊>临床肝胆病杂志 >我国药物性肝损伤流行病学研究现状

我国药物性肝损伤流行病学研究现状

     

摘要

Drug -induced liver injury (DILI) has been taken more and more seriously by governmental authorities , pharmaceutical companies,clinical physicians, and the general public.An understanding of the incidence, and distribution of DILI and related drugs is helpful for the prevention, clinical diagnosis, and treatment of DILI and may also help the government to perfect related laws and regulations and reduce the incidence of adverse drug reactions .This article reviews the epidemiology of DILI in China .%药物性肝损伤(DILI)的重要性已越来越多地引起政府医药主管部门、制药公司、临床工作者以及普通公众的重视.了解我国DILI的发生率、分布、常见诱发药物等流行病学特征,有助于DILI的预防、临床诊断和治疗,也有助于政府完善有关法规,降低药物不良反应的发生.现就我国DILI的流行病学现状作一阐述.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号